ORCHPHARMANSEOrchid Pharma LimitedMinimalNeutral
Announced Thu, 8 Jan · 16:32 IST

Orchid Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

ORCHPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Orchid Pharma Limited has submitted a Compliance Certificate to the stock exchanges under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the third quarter of FY2025-26, ending December 31, 2025. It was issued by M/s. Abhipra Capital Limited, the company's Registrar and Share Transfer Agent, confirming compliance with the regulation. Copies were also sent to NSDL and CDSL, the two depositories. This is a routine quarterly regulatory filing required of all listed companies.

Likely market impact

This is a routine compliance filing with no material impact on the business, financials, or share price. It simply confirms that the company's registrar has fulfilled its quarterly obligations under SEBI's depository rules.